SearcharxivSearch

arXiv subjects

Scott R. Sponheim

Publications and source records attributed to Scott R. Sponheim.

2 recordsLinked to original sources

Bayesian Inference of Psychometric Variables From Brain and Behavior in Implicit Association Tests

Objective. We establish a principled method for inferring mental health related psychometric variables from neural and behavioral data using the Implicit Association Test (IAT) as the data generation engine, aiming to overcome the limited predictive performance (typically under 0.7 AUC) of the gold-standard D-score method, which relies solely on reaction times. Approach. We propose a sparse hierarchical Bayesian model that leverages multi-modal data to predict experiences related to mental illness symptoms in new participants. The model is a multivariate generalization of the D-score with trainable parameters, engineered for parameter efficiency in the small-cohort regime typical of IAT studies. Data from two IAT variants were analyzed: a suicidality-related E-IAT ($n=39$) and a psychosis-related PSY-IAT ($n=34$). Main Results. Our approach overcomes a high inter-individual variability and low within-session effect size in the dataset, reaching AUCs of 0.73 (E-IAT) and 0.76 (PSY-IAT) in the best modality configurations, though corrected 95% confidence intervals are wide ($\pm 0.18$) and results are marginally significant after FDR correction ($q=0.10$). Restricting the E-IAT to MDD participants improves AUC to 0.79 $[0.62, 0.97]$ (significant at $q=0.05$). Performance is on par with the best reference methods (shrinkage LDA and EEGNet) for each task, even when the latter were adapted to the task, while the proposed method was not. Accuracy was substantially above near-chance D-scores (0.50-0.53 AUC) in both tasks, with more consistent cross-task performance than any single reference method. Significance. Our framework shows promise for enhancing IAT-based assessment of experiences related to entrapment and psychosis, and potentially other mental health conditions, though further validation on larger and independent cohorts will be needed to establish clinical utility.

cs.LG

Interoception Underlies The Therapeutic Effects of Mindfulness Meditation for Post-Traumatic Stress Disorder: A Randomized Clinical Trial

Mindfulness-based interventions have proven its efficacy in treating post-traumatic stress disorder (PTSD), but the underlying neurobiological mechanism is unknown. To determine the neurobiological mechanism of action of mindfulness-based stress reduction (MBSR) treating PTSD, we conducted a randomized clinical trial (RCT) in which 98 veterans with PTSD were randomly assigned to receive MBSR therapy (n = 47) or present-centered group therapy (PCGT; n = 51; an active-control condition). Pre- and post-intervention measures of PTSD symptom severity (PTSD Checklist) and brain activity measures of electroencephalography (EEG) were assessed, including spectral power of spontaneous neural oscillatory activities during resting and meditation periods, time-frequency (TF) power of cognitive task-related brain responses, and TF power of heartbeat-evoked brain responses (HEBR) that reflect cardiac interoceptive brain responses during resting and meditation. Compared to controls, the MBSR group had greater improvements in PTSD symptoms, spontaneous EEG alpha (8-13 Hz) power in posterior sites, task-related frontal theta power (4-7 Hz in 140-220 ms post-stimulus), and frontal theta HEBR (3-5 Hz and 265-328 ms post-R-peak). Latent difference score modeling found that only the changes in the frontal theta HEBR mediated the MBSR treatment effect. Brain source-level analysis found that the theta HEBR changes in the anterior cingulate cortex, anterior insular cortex, and the lateral prefrontal cortex predicted PTSD symptom improvements. These results indicated that mindfulness meditation improves spontaneous brain activities reflecting internally oriented relaxation and brain functions of attentional control. However, interoceptive brain capacity enhanced by MBSR appears to be the primary cerebral mechanism that regulates emotional disturbances and improves anxiety symptoms of PTSD.

q-bio.NC